Study of Early Warning Efficiency of Different Laboratory Markers in Predicting Progression of Disease in COVID-19

被引:0
|
作者
Krishnamurthy, Vishwanath [1 ]
Suhail, K. Mohammed [1 ]
Aslam, S. Shaikh Mohammed [1 ]
Raj, Madhu P. [1 ]
Patil, Prashanth [1 ]
Phaniraj, Priyanka [1 ]
机构
[1] MS Ramaiah Med Coll & Hosp, Dept Internal Med, Bengaluru, Karnataka, India
关键词
C reactive protein; early warning efficiency; Eosinopenia; progression of disease in COVID-19;
D O I
10.4103/aam.aam_117_21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: COVID 19 pandemic has given rise to several challenges to clinicians and one of the keys in this is to predict the set of patients who progress from mild disease to moderate and severe. Apart from the symptomatology and signs, there are several lab parameters varying from biochemical, hematological to radiological parameters which help us in stratifying the stage of disease and also in deciding on which set of patients need close and vigilant monitoring. This would help us in better stratification of disease and utilize the available infrastructure and resources in an optimum way for better management of the disease. Aim: To analyze the early warning efficiency of laboratory parameters individually or in combination in predicting the progress of disease in patients from mild to moderate/severe disease. Materials and Methods: This was taken up as a retrospective study with 100 cases and 100 controls. The demographic details, inflammatory markers, biochemical markers and hematological markers were analyzed. Test of significance was employed to compare categorical variables while student t-test was employed to test the difference in the mean value such as age between case and control (Mann-Whitney U-test in parameters not having normal distribution). Receiver operating characteristic (ROC) curve was constructed for these parameters using cases and controls and area under the curve (AUC) were estimated which was used as an indicator of sensitivity and specificity of the parameter in their early warning efficiency. The critical values for each of the parameters either individually or in combination was estimated as well. Results: Among the parameters C reactive protein (CRP), d-dimers and eosinopenia have the best early warning efficiency. The area under the ROCs curve for neutrophil lymphocyte ratio (NLR), CRP. Ferritin, lactate dehydrogenase, Eosinopenia was 0.609, 0.947, 0.614, 0.554, 0.617 respectively at triage. However, a combination of eosinopenia with CRP (AUC-0.732) or NLR with CRP (AUC-0.728) have a good sensitivity and specificity in predicting the outcome regarding the progression of the disease. Conclusions: Among the parameters, CRP, d-dimers, Eosinopenia and NLR have the best early warning efficiency. However, a combination of Eosinopenia and CRP at triage should also serve as a red flag sign in patients apart from the well-known NLR and IL6 values.
引用
收藏
页码:371 / 376
页数:6
相关论文
共 50 条
  • [1] Molecular markers for early stratification of disease severity and progression in COVID-19
    Kashyap, Anusha
    Sebastian, Savitha Anne
    NarayanaSwamy, Sree Raksha Krishnaiyer
    Raksha, KalyanKumar
    Krishnamurthy, Hanumanthappa
    Krishna, Bhuvana
    D'Souza, George
    Idiculla, Jyothi
    Vyas, Neha
    BIOLOGY METHODS & PROTOCOLS, 2022, 7 (01):
  • [2] Inflammatory markers and COVID-19 disease progression
    Sidhwani, Santosh Kumar
    Mirza, Talat
    Khatoon, Ambrina
    Shaikh, Fouzia
    Khan, Rizma
    Shaikh, Omer Ahmed
    Nashwan, Abdulqadir J.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (09) : 1386 - 1391
  • [3] Laboratory markers associated with COVID-19 progression in patients with or without comorbidity: A retrospective study
    Chen, Zaishu
    Zhang, Furong
    Hu, Weihua
    Chen, Qijian
    Li, Chang
    Wu, Longlong
    Zhang, Zhuheng
    Li, Bin
    Ye, Qifa
    Mei, Jin
    Yue, Jiang
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (01)
  • [4] Clinical value of laboratory indicators for predicting disease progression and death in patients with COVID-19: a retrospective cohort study
    Wang, Qian
    Cheng, Jie
    Shang, Jian
    Wang, Ying
    Wan, Jing
    Yan, You-qin
    Liu, Wen-bin
    Zhang, Hai-Ping
    Wang, Jian-ping
    Wang, Xiao-yue
    Li, Zi-ang
    Lin, Jun
    BMJ OPEN, 2021, 11 (10):
  • [5] Development and validation of COEWS (COVID-19 Early Warning Score) for hospitalized COVID-19 with laboratory features: A multicontinental retrospective study
    Klen, Riku
    Huespe, Ivan A.
    Gregalio, Felipe Anibal
    Blanco, Antonio Lalueza Lalueza
    Jimenez, MiguelPedrera
    Barrio, Noelia Garcia
    Valdez, Pascual Ruben
    Mirofsky, Matias A.
    Boietti, Bruno
    Gomez-Huelgas, Ricardo
    Casas-Rojo, Jose Manuel
    Anton-Santos, Juan Miguel
    Pollan, Javier Alberto
    Gomez-Varela, David
    ELIFE, 2023, 12
  • [6] The Value of Common Laboratory Markers in Predicting the Severity of COVID-19 Patients
    Chen, Lian
    Jiang, Yu-Huan
    Li, Mei-Yong
    Huang, Bo
    Yuan, Lei
    Wan, Jin-Hua
    Qin, Ting-Yu
    Zeng, Ting-Ting
    Chen, Qing-Gen
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 5037 - 5047
  • [7] Association of Inflammatory Markers With Disease Progression and the Severity of COVID-19
    Patel, Stuti V.
    Pathak, Jaya M.
    Parikh, Radhay J.
    Pandya, Karan J.
    Kothari, Priyal B.
    Patel, Arushi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [8] Clinical Laboratory Markers in COVID-19
    Iqbal, Mohammad Zahidul
    Zohra, Benazeer
    ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2021, 27 (04): : 576 - 585
  • [9] A Smart Early Warning System for Disease Outbreak with a Case Study of COVID-19 in India
    Kelhe, Tejashri
    Jain, Chaitanyasuma
    Bhandarkar, Mansi
    Deshpande, Ashwini
    2020 IEEE PUNE SECTION INTERNATIONAL CONFERENCE (PUNECON), 2020, : 113 - 118
  • [10] The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study
    Zheng, Yufen
    Zhang, Ying
    Chi, Hongbo
    Chen, Shiyong
    Peng, Minfei
    Luo, Lifei
    Chen, Linping
    Li, Jun
    Shen, Bo
    Wang, Donglian
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (07) : 1106 - 1115